FIELD: organic chemistry. SUBSTANCE: product of the formula (I) where R1 hydrogen, C1-C6-alkyl or phenylalkyl with C7-C12; R2 hydrogen, C1-C6-alkyl, C2-C6-alkenyl or phenylalkyl with C7-C12 or R1 and R2 together a group CH2-CH2-(CH2)-CR6R7-CH2 or -(CH2)-CR8R9-CR10R11-CH2- in which R6, R8, R10 independently each of other hydrogen, C1-C6-alkyl or hydroxyl; R7, R9, R11 independently each of other hydrogen or C1-C6-alkyl; A C1-C6-alkylene or C1-C6-alkenylene; X a group -C(O)OR3 at R3 hydrogen, C1-C6-alkyl or P(O)(OR4)(OR5) at R4, R5 independently each of other hydrogen, C1-C6-alkyl, 3,5-dioxo -1,2,4-oxadiazolidine-2-yl or 5-tetrazolyl, or their pharmaceutically acceptable salts. Reagent 1: compounds of the formula (II) where R1 as indicated above, R12 alkoxy, aralkoxy-substituted group containing C1-C5 or C7-C12/ . Reagent 2: compound of the formula HNR2-A-X where R2, A and X as indicated above. Reaction conditions: in the medium of solvent, at the room temperature or at heating. Synthesized compounds were used as anticonvulsive and neuroprotective agents at excessive release of exciting amino acids. EFFECT: improved method of synthesis. 1 tbl
Title |
Year |
Author |
Number |
METHOD OF SYNTHESIS OF [2-((8,9)-DIOXO-2,6-DIAZOBI-CYCLO-[5,2,0]NON-1(7)-EN-2-YL)ETHYL]PHOSPHONIC ACID, METHOD OF SYNTHESIS OF N-[3-(TERTIARY BUTYLOXY- CARBONYLAMINO)PROPYL]-2-AMINOETHYLPHOSPHONIC ACID DI-C-C-ALKYL ESTER, COMPOUNDS |
1998 |
- Asselin Andre Al'Fred
- Kinni Uill'Jam Ehlvin
- Shmid Dzhin
|
RU2205834C2 |
RAPAMYCIN DERIVATIVES, A PHARMACEUTICAL COMPOSITION AND A METHOD OF IMMUNODEPRESSION STIMULATING |
1993 |
- Venling Kao
- Magid A.Abou-Gkharbia
- Robert L.Vogel
|
RU2126409C1 |
METHOD OF OBTAINING SUBSTITUTED 1,3,4,9-TETRAHYDROPYRANO/3,4-INDOLE-1-ACETIC/ ACIDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF |
0 |
- Alan Khovard Kats
- Kristofer Aleksandr Demerson
- Lesli Dzhordzh Khamber
|
SU1531856A3 |
OXIME CARBAMATES AND OXIME CARBONATES |
1991 |
|
RU2051145C1 |
DERIVATIVES OF SPIRO-[ISOQUINOLINE-4-(1H)-3-PYRROLIDINE]-1,2',3,5'-(2H)-TETR- -ONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION USED FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS-RELATED COMPLICATIONS |
1991 |
- Majkl Sotirios Malamas[Gr]
|
RU2110518C1 |
DERIVATIVES OF SUBSTITUTED BENZOYLBENZENE-, BIPHENYL OR 2-OXAZOLEALKANOIC ACID OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS, AND A METHOD OF THEIR SYNTHESIS |
1992 |
- Amedeo Arturo Fejlli[Us]
- Ehntoni Frehnk Kreft Iii[Us]
- Dzhon Genri Musser[Us]
|
RU2037481C1 |
|
0 |
- Kurt Villi Ledig
- Devid Richard Kherbst
|
SU512713A1 |
C-22 STABILIZED DERIVATIVES OF RAPAMYCIN, METHOD OF IMMUNO- -SUPPRESSION INDUCING, METHOD OF TREATMENT AND PROPHYLAXIS OF TRANSPLANT REJECTION OR HOMOLOGOUS DISEASE, METHOD OF TREATMENT OR PROPHYLAXIS OF HYPERPROLIFERATIVE VASCULAR DISORDER |
1994 |
|
RU2152946C1 |
METHOD OF PREPARING BENZYLAMINE DERIVATIVES OR SALTS THEREOF |
0 |
- Dzhon Patrik Yardli
- Piter Birom Rassell
|
SU571188A3 |
SUBSTITUTED PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR N-OXIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1992 |
- Dzhon Vatson Ehllingboj
- Madelen Nikajdo
- Zhak Framros Bazhli
|
RU2113437C1 |